Alto Neuroscience ANRO Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.94M+22.6% | $45.62M+2.7% | $44.42M-5.4% | $46.96M-0.1% | $47.02M0.0% | ||
| $21.89M+5.5% | $20.75M-5.2% | $21.88M-6.0% | $23.28M+1.8% | $22.88M+5.9% | ||
| $77.83M+17.3% | $66.36M+0.1% | $66.31M-5.6% | $70.24M+0.5% | $69.9M+1.9% | ||
| $77.83M+17.3% | $66.36M+0.1% | $66.31M-5.6% | $70.24M+0.5% | $69.9M+1.9% | ||
| -$77.83M-17.3% | -$66.36M-0.1% | -$66.31M+5.6% | -$70.24M-0.5% | -$69.9M-1.9% | ||
| $2.42M-2.1% | $2.47M+10.9% | $2.23M+15.6% | $1.93M+18.4% | $1.63M+18.3% | ||
| $6.34M-4.0% | $6.6M-8.0% | $7.18M-11.9% | $8.15M-10.7% | $9.12M+3.0% | ||
| $3.52M+12.6% | $3.13M-22.8% | $4.05M-24.8% | $5.38M-19.9% | $6.72M-6.4% | ||
| $0+100% | -$681K0.0% | -$681K0.0% | -$681K0.0% | -$681K— | ||
| -$74.31M-17.5% | -$63.24M-1.6% | -$62.26M+4.0% | -$64.86M-2.7% | -$63.18M-2.9% | ||
| -$2.42-11.0% | -$2.18+4.8% | -$2.29+4.2% | -$2.39-2.1% | -$2.34+7.9% | ||
| -$2.42-11.0% | -$2.18+4.8% | -$2.29+4.2% | -$2.39-2.1% | -$2.34+7.9% | ||
| 115.9M+5.3% | 110.1M+4.0% | 105.8M+0.1% | 105.7M+0.2% | 105.5M+9.8% | ||
| 115.9M+5.3% | 110.1M+4.0% | 105.8M+0.1% | 105.7M+0.2% | 105.5M+9.8% | ||
| $26K-83.0% | $153K+6.3% | $144K-7.7% | $156K+16.4% | $134K— | ||
| -$74.31M-17.7% | -$63.12M-1.6% | -$62.15M+4.0% | -$64.74M-2.6% | -$63.09M-2.7% | ||
| -$77.83M-17.3% | -$66.36M-0.1% | -$66.31M+5.6% | -$70.24M-0.5% | -$69.9M-1.9% | ||
| -$77.19M-17.4% | -$65.74M-0.1% | -$65.67M+5.7% | -$69.6M-0.5% | -$69.26M-1.8% | ||
| -$77.19M-17.4% | -$65.74M-0.1% | -$65.67M+5.7% | -$69.6M-0.5% | -$69.26M-1.8% | ||
| -$77.83M-17.3% | -$66.36M-0.1% | -$66.31M+5.6% | -$70.24M-0.5% | -$69.9M-1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Alto Neuroscience profitable?
- Alto Neuroscience is not currently profitable: it reported a net loss of $74.3M over the trailing twelve months.
- What is Alto Neuroscience's earnings per share?
- Alto Neuroscience's diluted EPS over the trailing twelve months is $-2.42.
- Where does Alto Neuroscience's income statement data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.